Results 171 to 180 of about 62,762 (312)

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Associations of oral contraceptives and hormone replacement therapy with incident dementia risk: a population-based cohort study. [PDF]

Transl Psychiatry
Ou YN, Liu X, Gao PY, Yang L, Feng JF, Tan L, Yu JT, Song JH.   +7 more
europepmc   +1 more source

Oral contraceptives and bone mineral density - Reply

, 2001
Oral contraceptives and bone mineral density ...
GC Nicholson (14448297), MA Kotowicz (14448495), JA Passo (14530742)   +2 more
core  

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Comparison of Substances in Combined Oral Contraceptives Used in Acne Vulgaris, Hirsutism, Migraine, and Dysmenorrhea. [PDF]

Med Sci Monit
Wójcikiewicz P, Durlej G, Satora M, Tarkowski R, Kułak K.   +4 more
europepmc   +1 more source

Safety of Oral Contraceptives [PDF]

BMJ, 1966
openaire   +2 more sources

Oral contraceptives, migraine and quality of life

, 2019
Oral contraceptives, migraine and quality of ...
Julie von Trepka Høiseth
core  

Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?

ESC Heart Failure, Volume 12, Issue 2, Page 1447-1454, April 2025.
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo, Daniela Di Lisi, Antonio Cannatà, Federica Manfrè, Celeste Vullo, Marco Santoro, Ciro Botta, Salvatrice Mancuso, Sergio Siragusa, Alfredo Ruggero Galassi, Giuseppina Novo   +10 more
wiley   +1 more source

The rapid growth in the use of hormonal contraceptives gives grounds for assessing their influence on various biochemical parameters of the human system since its safety has become arguable and in doubt. This study investigated the effects of oral contrac

Sokoto Journal of Medical Laboratory Science
The rapid growth in the use of hormonal contraceptives gives grounds for assessing their influence on various biochemical parameters of the human system since its safety has become arguable and in doubt.
Etura Joyce Ezekiel and Ogar, Agnes Oka
doaj  

Optimizing inpatient access to oral contraceptives: A quality improvement approach in behavioral health. [PDF]

Explor Res Clin Soc Pharm
Pierce RS, Crews DN, Pierce BJ, Wulffson CK.   +3 more
europepmc   +1 more source